14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $23.53 $28.69 Friday, 3rd May 2024 INSM stock ended at $25.55. This is 0.429% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.06% from a day low at $25.40 to a day high of $26.43.
90 days $23.53 $29.91
52 weeks $18.09 $32.00

Historical Insmed prices

Date Open High Low Close Volume
Nov 02, 2023 $24.95 $25.19 $24.34 $25.01 1 099 263
Nov 01, 2023 $25.20 $25.59 $24.88 $24.99 949 170
Oct 31, 2023 $23.72 $25.10 $23.65 $25.06 1 041 456
Oct 30, 2023 $24.04 $24.67 $23.75 $23.80 1 032 873
Oct 27, 2023 $26.00 $26.00 $23.62 $23.88 1 986 013
Oct 26, 2023 $25.49 $25.94 $25.16 $25.55 1 362 601
Oct 25, 2023 $24.90 $25.91 $24.90 $25.45 1 558 023
Oct 24, 2023 $25.36 $25.97 $24.86 $25.05 1 600 327
Oct 23, 2023 $24.88 $25.41 $24.57 $24.90 1 080 833
Oct 20, 2023 $25.45 $25.63 $24.84 $25.08 1 079 036
Oct 19, 2023 $25.39 $26.00 $25.15 $25.23 926 944
Oct 18, 2023 $25.78 $25.98 $25.20 $25.28 802 797
Oct 17, 2023 $25.27 $25.98 $25.26 $25.70 1 382 283
Oct 16, 2023 $24.78 $25.23 $24.40 $25.08 1 133 777
Oct 13, 2023 $24.53 $24.78 $24.07 $24.76 721 847
Oct 12, 2023 $25.01 $26.00 $24.03 $24.46 969 121
Oct 11, 2023 $24.83 $25.12 $24.42 $25.09 838 211
Oct 10, 2023 $24.41 $25.00 $24.30 $24.81 1 058 526
Oct 09, 2023 $24.18 $24.64 $24.01 $24.51 731 424
Oct 06, 2023 $24.83 $25.17 $24.27 $24.44 1 102 070
Oct 05, 2023 $24.10 $25.08 $23.92 $25.04 1 267 518
Oct 04, 2023 $24.24 $24.36 $23.94 $24.15 892 788
Oct 03, 2023 $25.34 $25.53 $24.23 $24.32 1 221 960
Oct 02, 2023 $25.25 $25.52 $24.99 $25.37 1 082 854
Sep 29, 2023 $25.92 $25.96 $25.13 $25.25 818 196
Click to get the best stock tips daily for free!

About Insmed

Insmed Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr... INSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT